Platform comparison for evaluation of ALK protein immunohistochemical expression, genomic copy number and hotspot mutation status in neuroblastomas
10.1371/journal.pone.0106575
Saved in:
Main Authors: | Yan B., Kuick C.H., Lim M., Venkataraman K., Tennakoon C., Loh E., Lian D., Leong M.Y., Lakshmanan M., Tergaonkar V., Sung W.-K., Soh S.Y., Chang K.T.E. |
---|---|
Other Authors: | DEPARTMENT OF COMPUTER SCIENCE |
Format: | Article |
Published: |
Public Library of Science
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142475 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
by: Moore, N.F, et al.
Published: (2020) -
Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas
by: Yan, B., et al.
Published: (2014) -
Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
by: Guo, Y.A, et al.
Published: (2020) -
Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs
by: Vikhanskaya, F., et al.
Published: (2014) -
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
by: Kim, H.R., et al.
Published: (2014)